The term dysplasia refers to any type of abnormal physical development. It is most often used to refer to cellular abnormalities, which are often pre-cancerous, but can also be used to describe a deformation of the hip joint. Although severe dysplasia can indicate any type of high grade abnormalty, it is frequently used as a short-hand for severe cervical dysplasia, which can be a precursor of cervical cancer. Also known as carcinoma-in-situ, severe dysplasia is a condition in which the skin of the cervix is growing at an abnormally fast pace.
As a result of this abnormal growth, there is an increased amount of immature skin cells present on the surface of the skin or lining of the cervix. While this rapid growth of cells takes place on the surface of the cervix, the chances of developing into an invasive cancer are very high. This means early detection and treatment is extremely important.
Severe dysplasia is one of three different types of cervical dysplasia currently identified in medical circles. Mild dysplasia, also known as CIN 1, is a condition where there are relatively few immature skin cells present, although more than considered normal. Moderate dysplasia, or CIN 2, has a higher and more widely disbursed amount of immature cells. The third category of severe dysplasia, or CIN 3, is the most serious category, since the number of immature cells is extremely high and is causing a noticeable change in the thickness of the surface layer of the cervix.
One of the conditions that can trigger severe dysplasia is known as the human papillomavirus, or HPV. This virus can infect different types of epidermal layers as well as the mucous membranes in the human body. HPV can pave the way for cancers in several parts of the body, including cervical cancer.
Detecting severe dysplasia involves the use of a Pap smear. Samples obtained during the smear can be analyzed to determine the presence as well as the current status of the dysplasia. This allows the physician to take action before there is a chance for the proliferation of immature cells to begin penetrating the surface of the cervix and pave the way for the development of cervical cancer.
In some cases, there may also be evidence of what is known as a high-grade squamous intraepithelial lesion, or HGSIL. A lesion of this type is also identified during the course of a Pap smear, and is an indication of the presence of moderate to severe dysplasia. While not an indicator that cancer is already present, these lesions do indicate that conditions are rapidly approaching the point where cancer could develop.
When HGSIL is found, physicians usually order what is known as a colposcopy. This procedure involves the removal of samples of the tissue. In some cases, the dysplastic tissue is completely removed. In both scenarios, the removed tissue is submitted for biopsy, making it possible to confirm whether or not cancer is forming, and also to determine the current status of the dysplasia itself.
Additional treatments for severe dysplasia may involve the use of cryotherapy, some type of cauterizing, or even laser surgery to remove the excess skin cells. Physicians rarely employ any of these treatments if the female is currently pregnant, however, fearing that they could have an adverse effect on the pregnancy. Instead, the condition is monitored, and removal of the excess epidermal layer on the cervix is accomplished at some point after the delivery.